Wellington Management Group LLP Verastem, Inc. Transaction History

Wellington Management Group LLP

  • $531 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.92 - $11.16 $3.77 Million - $45.7 Million
4,096,738 Added 1104.98%
4,467,491 $0
Q1 2022

May 16, 2022
BUY
$1.06 - $2.1 $27,560 - $54,600
26,000 Added 7.54%
370,753 $522,000
Q4 2021

Feb 11, 2022
BUY
$2.05 - $3.2 $706,743 - $1.1 Million
344,753 New
344,753 $707,000

Others Institutions Holding VSTM

# of Institutions
5
Shares Held
297K
Call Options Held
0
Put Options Held
0
View Full List

About Verastem, Inc.

VSTM Quotes by TradingView
  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.18B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email